Summary

ICM.Quant platform obtains ISO 9001 certification

In August 2025, ICM.quant – Quantitative Cellular and Molecular Imaging Platform obtained ISO 9001 certification, recognizing the quality, rigour and performance of its organization.

This success is the culmination of an ambitious quality approach, initiated in 2024 and accompanied by the Organisation, Risk and Quality Management (ROQ) Cluster.

Obtaining this certificate confirms the maturity of the quality management system put in place by the platform and its strong commitment to continuous improvement.

A major asset for Paris Brain Institute

ISO 9001 certification is a strategic step for the Brain Institute:

  • Internally, it makes it possible to structure processes, strengthen traceability and facilitate coordination between scientific teams.
  • Externally, it strengthens the trust of partners and users, guaranteeing the quality, reliability and transparency of the services provided.

Collective recognition

This certification illustrates the dynamic quality committed throughout the Institute, in the service of scientific and operational excellence and recognizes the professional expertise of all the platform’s staff, their exemplary commitment and their rigorous work, which have made this success possible.